Logo of aacPermissionsJournals.ASM.orgJournalAAC ArticleJournal InfoAuthorsReviewers
Antimicrob Agents Chemother. Dec 1991; 35(12): 2467–2472.
PMCID: PMC245414

Evaluation of vancomycin for therapy of adult pneumococcal meningitis.

Abstract

The emergence of pneumococci resistant to penicillin and other agents prompted us to evaluate intravenous vancomycin for the therapy of pneumococcal meningitis, which has an overall mortality of 30%. Eleven consecutive adult patients with cerebrospinal fluid (CSF)-culture-proven pneumococcal meningitis and positive initial CSF Gram stain were given intravenous vancomycin (usual dosage, 7.5 mg/kg every 6 h for 10 days). The MBCs of vancomycin ranged from 0.25 to 0.5 micrograms/ml. Early adjunctive therapy with intravenous dexamethasone, mannitol, and sodium phenytoin was also instituted. After 48 h of therapy, all 11 patients showed a satisfactory clinical response, although the CSF culture remained positive in one case; median trough CSF and serum vancomycin levels were 2 and 5.1 micrograms/ml, respectively, and trough CSF bactericidal titers ranged from less than 1:2 to 1:16. On day 3, one patient died of acute heart failure. Four patients had clinical failure at on days 4 (two patients), 7 (one), and 8 (one) of therapy; they all immediately responded to a change in antibiotic therapy. The remaining six patients were cured after 10 days of vancomycin therapy. At this point, median peak CSF and serum vancomycin levels were 1.9 and 18.5 micrograms/ml, respectively. A transient alteration of renal function occurred in two patients, and persistent slight hypoacusia occurred in three patients. In summary, 11 adults with pneumococcal meningitis were treated with vancomycin and early adjunctive therapy including dexamethasone. All patients initially improved, and 10 were ultimately cured of the infection. However, four patients experienced a therapeutic failure, which led to a change in vancomycin therapy.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Appelbaum PC. World-wide development of antibiotic resistance in pneumococci. Eur J Clin Microbiol. 1987 Aug;6(4):367–377. [PubMed]
  • Brady MT, Kaplan SL, Taber LH. Association between persistence of pneumococcal meningitis and dexamethasone administration. J Pediatr. 1981 Dec;99(6):924–926. [PubMed]
  • Buzón LM, Guerrero A, Romero J, Santamaria JM, Bouza E. Penicillin-resistant Streptococcus pneumoniae meningitis successfully treated with vancomycin. Eur J Clin Microbiol. 1984 Oct;3(5):442–443. [PubMed]
  • Cagigas P, López-Herce J, Díez Enciso M, Ruza F. Meningitis por Streptococcus pneumoniae altamente resistente a la penicilina y no tratable con cefotaxima ni cloramfenicol. Med Clin (Barc) 1985 Dec 7;85(19):814–815. [PubMed]
  • Fenoll A, Martín Bourgon C, Muñz R, Vicioso D, Casal J. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989. Rev Infect Dis. 1991 Jan-Feb;13(1):56–60. [PubMed]
  • Garau J, Linares J, Dominguez C. Chloramphenicol-resistant pneumococci. Lancet. 1981 Jul 18;2(8238):147–148. [PubMed]
  • GEORGE RM, COCHRAN CP, WHEELER WE. Epidemic meningitis of the newborn caused by flavobacteria. II. Clinical manifestations and treatment. Am J Dis Child. 1961 Mar;101:296–304. [PubMed]
  • Winkelstein JA. The role of complement in the host's defense against Streptococcus pneumoniae. Rev Infect Dis. 1981 Mar-Apr;3(2):289–298. [PubMed]
  • Hawley HB, Gump DW. Vancomycin therapy of bacterial meningitis. Am J Dis Child. 1973 Aug;126(2):261–264. [PubMed]
  • Jackson MA, Shelton S, Nelson JD, McCracken GH., Jr Relatively penicillin-resistant pneumococcal infections in pediatric patients. Pediatr Infect Dis. 1984 Mar-Apr;3(2):129–132. [PubMed]
  • Jacobs MR, Mithal Y, Robins-Browne RM, Gaspar MN, Koornhof HJ. Antimicrobial susceptibility testing of pneumococci: determination of Kirby-Bauer breakpoints for penicillin G, erythromycin, clindamycin, tetracycline, chloramphenicol, and rifampin. Antimicrob Agents Chemother. 1979 Aug;16(2):190–197. [PMC free article] [PubMed]
  • Jolley ME, Stroupe SD, Schwenzer KS, Wang CJ, Lu-Steffes M, Hill HD, Popelka SR, Holen JT, Kelso DM. Fluorescence polarization immunoassay. iii. an automated system for therapeutic drug determination. Clin Chem. 1981 Sep;27(9):1575–1579. [PubMed]
  • Kadurugamuwa JL, Hengstler B, Zak O. Cerebrospinal fluid protein profile in experimental pneumococcal meningitis and its alteration by ampicillin and anti-inflammatory agents. J Infect Dis. 1989 Jan;159(1):26–34. [PubMed]
  • Kaiser AB, McGee ZA. Aminoglycoside therapy of gram-negative bacillary meningitis. N Engl J Med. 1975 Dec 11;293(24):1215–1220. [PubMed]
  • Liñares J, Perez JL, Garau J, Murgui L, Martín R. Comparative susceptibilities of penicillin-resistant pneumococci to co-trimoxazole, vancomycin, rifampicin and fourteen beta-lactam antibiotics. J Antimicrob Chemother. 1984 Apr;13(4):353–359. [PubMed]
  • McCracken GH, Jr, Lebel MH. Dexamethasone therapy for bacterial meningitis in infants and children. Am J Dis Child. 1989 Mar;143(3):287–289. [PubMed]
  • Nolan CM, McAllister CK, Walters E, Beaty HN. Experimental pneumococcal meningitis. IV. The effect of methyl prednisolone on meningeal inflammation. J Lab Clin Med. 1978 Jun;91(6):979–988. [PubMed]
  • Plotkin SA, McKitrick JC. Nosocomial meningitis of the newborn caused by a flavobacterium. JAMA. 1966 Nov 7;198(6):662–664. [PubMed]
  • Ryan JL, Pachner A, Andriole VT, Root RK. Enterococcal meningitis: combined vancomycin and rifampin therapy. Am J Med. 1980 Mar;68(3):449–451. [PubMed]
  • Scheld WM, Brodeur JP. Effect of methylprednisolone on entry of ampicillin and gentamicin into cerebrospinal fluid in experimental pneumococcal and Escherichia coli meningitis. Antimicrob Agents Chemother. 1983 Jan;23(1):108–112. [PMC free article] [PubMed]
  • Sutherland GE, Palitang EG, Marr JJ, Luedke SL. Sterilization of Ommaya reservoir by instillation of vancomycin. Am J Med. 1981 Dec;71(6):1068–1070. [PubMed]
  • SWARTZ MN, DODGE PR. BACTERIAL MENINGITIS--A REVIEW OF SELECTED ASPECTS. 1. GENERAL CLINICAL FEATURES, SPECIAL PROBLEMS AND UNUSUAL MENINGEAL REACTIONS MIMICKING BACTERIAL MENINGITIS. N Engl J Med. 1965 Apr 15;272:779–CONTD. [PubMed]
  • Tunkel AR, Wispelwey B, Scheld WM. Bacterial meningitis: recent advances in pathophysiology and treatment. Ann Intern Med. 1990 Apr 15;112(8):610–623. [PubMed]
  • Viladrich PF, Gudiol F, Liñares J, Rufi G, Ariza J, Pallares R. Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci. Am J Med. 1988 May;84(5):839–846. [PubMed]
  • Wenger JD, Hightower AW, Facklam RR, Gaventa S, Broome CV. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J Infect Dis. 1990 Dec;162(6):1316–1323. [PubMed]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Compound
    Compound
    PubChem Compound links
  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...